Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NATAN: Zoledronic acid in residual breast cancer
NCT00512993Phase 3Completed
- Sponsor
- GBG Forschungs
- Start
- Dec 2004
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of zoledronic acid in breast cancer, sponsored by GBG Forschungs. Started Dec 2004; status: completed.
02
Drugs
zoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00512993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00512993.